Skip to content
DilutionScan
Atrium Therapeutics, Inc. logo
RNA$6.43-14.38%

Atrium Therapeutics, Inc.

Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq

Mkt Cap & EV$138.7M /
Float & O/S15.88M / 21.57M
Est. Net Cash/Sh
Inst Own64.3%

DilutionScan read 28 of Atrium Therapeutics, Inc.'s SEC filings and found 1 warrant series and 1 completed offering on file for RNA. The latest dilution event on file is an offering on Oct 9, 2026. Analysis updated Nov 14, 2026.

Signal8 Summary

Raise routes on file: no active ATM, effective shelf, issuer S-1 or active equity line in the filings read · latest dilution event 38 days ago

Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need

AI dilution summary

The dominant contractual driver and its mechanism, then each further driver ranked.

Latest dilution event

Oct 9, 2026 · Offering

How we read filings

Every warrant, convertible, ATM and shelf, cited to the filing

A free account reads 3 tickers a day in full

Get Pro · every ticker

From $29.99/mo. Signal8 Pro is $49/mo, or $40.67/mo billed yearly ($488/yr)

Share count and cash history

Shares outstanding, potential dilution and cash over time

Warrants · 1

What is this?

Exercise price, shares and dates with Pro

Pre-Funded Warrants (October 2026 PIPE)

Issued 2026

Outstanding

Shares Underlying

Exercise Price

Outstanding
Type
Anti-Dilution
Cashless Exercise
Expiration
Filing link and full terms

Offerings · 1

What is this?

Proceeds, price, shares and agent with Pro

PIPE

Issued 2026

Gross proceeds

Price per share

Shares issued
Warrant coverage
Placement agent
Filing link and full terms

Know who's about to sell into your RNA trade

Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.

Get Pro · every ticker

From $29.99/mo. Signal8 Pro is $49/mo, or $40.67/mo billed yearly ($488/yr)

DilutionScanEvery instrument in full · From $29.99/mo